Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125998272 | 12599827 | 2 | F | 201510 | 20160418 | 20160727 | 20160823 | PER | US-MYLANLABS-2016M1016288 | MYLAN | 80.71 | YR | F | Y | 0.00000 | 20160823 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125998272 | 12599827 | 1 | PS | CLONIDINE. | CLONIDINE | 1 | Transdermal | 0.1 MG, QD, CHANGED OW | N | 76166 | .1 | MG | TRANSDERMAL PATCH | QD | |||||
| 125998272 | 12599827 | 2 | SS | CLONIDINE TEVA /00171101/ | CLONIDINE | 1 | UNK | 0 | TRANSDERMAL PATCH | ||||||||||
| 125998272 | 12599827 | 3 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | N | 0 | ||||||||||
| 125998272 | 12599827 | 4 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | N | 0 | ||||||||||
| 125998272 | 12599827 | 5 | SS | CAPTOPRIL. | CAPTOPRIL | 1 | Oral | 25 MG, 6XD | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125998272 | 12599827 | 1 | Blood pressure measurement |
| 125998272 | 12599827 | 2 | Blood pressure management |
| 125998272 | 12599827 | 3 | Blood pressure management |
| 125998272 | 12599827 | 4 | Infection |
| 125998272 | 12599827 | 5 | Blood pressure management |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125998272 | 12599827 | Alopecia | |
| 125998272 | 12599827 | Amnesia | |
| 125998272 | 12599827 | Breast enlargement | |
| 125998272 | 12599827 | Drug interaction | |
| 125998272 | 12599827 | Nervous system disorder | |
| 125998272 | 12599827 | Palpitations | |
| 125998272 | 12599827 | Peripheral swelling | |
| 125998272 | 12599827 | Rash morbilliform | |
| 125998272 | 12599827 | Skin discolouration | |
| 125998272 | 12599827 | Skin injury | |
| 125998272 | 12599827 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125998272 | 12599827 | 3 | 201510 | 201510 | 0 | |
| 125998272 | 12599827 | 4 | 201510 | 201510 | 0 |